Difference between revisions of "User:Ahmad.A.Aref"

From EyeWiki
(Approved account)
 
Line 1: Line 1:
 
 
{{User
 
{{User
 
|Approved=Yes
 
|Approved=Yes
|Name=Ahmad A. Aref, MD
+
|Name=Ahmad A. Aref, MD, MBA
 
|Location=Chicago, IL, USA
 
|Location=Chicago, IL, USA
 
|Affiliation=Illinois Eye & Ear Infirmary, University of Illinois at Chicago School of Medicine
 
|Affiliation=Illinois Eye & Ear Infirmary, University of Illinois at Chicago School of Medicine
|Financial disclosures=None
+
|Financial disclosures=Aerie Pharmaceuticals (S), New World Medical, Inc (C)
 +
|Ophthalmologist=Yes
 +
|Subspecialty=Glaucoma/Anterior Segment
 +
|Degree type=MD, MBA
 
}}
 
}}

Latest revision as of 06:45, September 20, 2019

Name
Ahmad A. Aref, MD, MBA

Location
Chicago, IL, USA

Affiliation
Illinois Eye & Ear Infirmary, University of Illinois at Chicago School of Medicine

Financial Disclosures
Aerie Pharmaceuticals (S), New World Medical, Inc (C)

Public E-mail or Contact
add

Ophthalmologist
Yes

Subspecialty
Glaucoma/Anterior Segment

Degree type
MD, MBA

Contributions
Ahmad A. Aref, MD, MBA is listed as an author of Bimatoprost Implant (Durysta), Cannabinoids for Glaucoma, Hydrus Microstent